Self-assembled microtissues loaded with osteogenic MSCs for in vivo bone regeneration

Bone regeneration strategies based on mesenchymal stem cell (MSC) therapy have received widespread attention. Although MSC incorporation into bone scaffolds can help with the repair process, a large number of studies demonstrate variable effects of MSCs with some noting that the inclusion of MSCs does not provide better outcomes compared to unseeded scaffolds. This may in part be related to low cell survival following implantation and/or limited ability to continue with osteogenic differentiation for pre-differentiated cells. In this study, we incorporated MSCs into gelatin microcryogels to form microtissues, and subjected these microtissues to osteogenic induction. We then mixed as-formed microtissues with those subjected to 6 days of osteogenic induction in different ratios, and investigated their ability to induce in vitro and in vivo osteogenesis during self-assembly. Using a full-thickness rat calvarial defect model, we found that undifferentiated and osteogenically induced microtissues mixed in a ratio of 2:1 produced the best outcomes of bone regeneration. This provides a new, customizable cell-based therapeutic strategy for in vivo repair of bone defects.

[1]  Y. Yahata,et al.  Clinical Applications of Cell-Scaffold Constructs for Bone Regeneration Therapy , 2021, Cells.

[2]  Rachel E. Brewer,et al.  Aged skeletal stem cells generate an inflammatory degenerative niche , 2021, Nature.

[3]  Yan Jin,et al.  Advancing application of mesenchymal stem cell-based bone tissue regeneration , 2020, Bioactive materials.

[4]  Cheng Lyu,et al.  Engineering 3D functional tissue constructs using self-assembling cell-laden microniches. , 2020, Acta biomaterialia.

[5]  S. Vimalraj Alkaline Phosphatase: Structure, Expression and its Function in Bone Mineralization. , 2020, Gene.

[6]  K. Bdeir,et al.  The secreted protein DEL-1 activates a β3 integrin–FAK–ERK1/2–RUNX2 pathway and promotes osteogenic differentiation and bone regeneration , 2020, The Journal of Biological Chemistry.

[7]  J. Kuiper,et al.  Predictors of fracture healing in patients with recalcitrant nonunions treated with autologous culture expanded bone marrow‐derived mesenchymal stromal cells , 2019, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[8]  Heungsoo Shin,et al.  Current Advances in Immunomodulatory Biomaterials for Bone Regeneration , 2018, Advanced healthcare materials.

[9]  V. Alt,et al.  Diaphyseal long bone nonunions — types, aetiology, economics, and treatment recommendations , 2018, International Orthopaedics.

[10]  A. Mizokami,et al.  Osteocalcin and its endocrine functions. , 2017, Biochemical pharmacology.

[11]  V. Crincoli,et al.  Bone Regeneration Induced by Bone Porcine Block with Bone Marrow Stromal Stem Cells in a Minipig Model of Mandibular “Critical Size” Defect , 2017, Stem cells international.

[12]  Dennis Mathew,et al.  Biomimetic composite scaffolds containing bioceramics and collagen/gelatin for bone tissue engineering - A mini review. , 2016, International journal of biological macromolecules.

[13]  H. Qiao,et al.  AMPK promotes osteogenesis and inhibits adipogenesis through AMPK-Gfi1-OPN axis. , 2016, Cellular signalling.

[14]  G. Wilson,et al.  Isolation and comparative analysis of potential stem/progenitor cells from different regions of human umbilical cord. , 2016, Stem cell research.

[15]  S. Mehta,et al.  Biological Risk Factors for Nonunion of Bone Fracture , 2016, JBJS reviews.

[16]  Cato T Laurencin,et al.  Biomaterials for Bone Regenerative Engineering , 2015, Advanced healthcare materials.

[17]  Philippe Rosset,et al.  Bone fracture healing: cell therapy in delayed unions and nonunions. , 2015, Bone.

[18]  T. Yoneda,et al.  Isolation and characterization of the human immature osteoblast culture system from the alveolar bones of aged donors for bone regeneration therapy , 2014, Expert opinion on biological therapy.

[19]  J. Schroeder,et al.  Stem cell-based therapy for prevention of delayed fracture union: a randomized and prospective preliminary study. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[20]  T. Le,et al.  Tibia shaft fractures: costly burden of nonunions , 2013, BMC Musculoskeletal Disorders.

[21]  D. Graves,et al.  Molecular Mechanisms Controlling Bone Formation during Fracture Healing and Distraction Osteogenesis , 2008, Journal of dental research.

[22]  P. Giannoudis,et al.  Fracture healing: the diamond concept. , 2007, Injury.

[23]  K. Kraus,et al.  Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. , 2003, The Journal of bone and joint surgery. American volume.

[24]  J. Deng,et al.  The Novel Zinc Finger-Containing Transcription Factor Osterix Is Required for Osteoblast Differentiation and Bone Formation , 2002, Cell.

[25]  M. McKee,et al.  Osteopontin: an interfacial extracellular matrix protein in mineralized tissues. , 1996, Connective tissue research.